Sara Betzhold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sara Betzhold has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ann-Kristin Folkerts
Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
1 shared publication - Dag Aarsland
Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway
1 shared publication - Elke Kalbe
Medical Psychology | Neuropsychology and Gender Studies, Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne Cologne Germany
1 shared publication - Emilia Grycuk
School of Medicine Trinity College Dublin Dublin Ireland
1 shared publication - Emily Eichenholtz
Department of Neuroscience Columbia University New York New York USA
1 shared publication - Federico Rodriguez-Porcel
Department of Neurology, Medical University of South Carolina, Charleston, USA
1 shared publication
Latest Publications
- Open Access
- 11 July 2025
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 11 (3) , e70134
A common outcome set for trials in dementia with Lewy bodies (DLB COS)
INTRODUCTION: Methodological heterogeneity in dementia with Lewy bodies (DLB) trials contributes to publication bias and makes evidence synthesis and meta‐analysis challenging. We aimed to develop a core outcome set for DLB (DLB COS) trials to improve consistency and comparability in DLB research. METHODS: We conducted a systematic review to identify outcomes and administered a two‐stage Delphi survey to a diverse panel of lay and professional stakeholders. We asked respondents which outcomes should be prioritized and included in DLB COS. RESULTS: Forty‐nine outcomes were presented to survey respondents. Consensus was reached regarding eight outcomes for the final DLB COS: delusions/paranoia; fluctuations in cognition, attention, and arousal; functioning; global cognition; hallucinations; quality of life; motor parkinsonism; and rapid eye movement sleep behavior disorder. DISCUSSION: If adopted, DLB COS can enhance the comparability of research findings and facilitate standardization and harmonization. Highlights: A systematic review revealed heterogeneity in dementia with Lewy bodies (DLB) study outcomes. Our study produced a DLB Core Outcome Set (DLB COS) comprising eight outcomes. DLB COS sets the minimum reporting standards for future trials. DLB‐specific rating scales incorporating these outcomes are needed. Addressing this gap is a strategic priority in DLB research.
- 11 July 2025
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 11 (3) , e70134
Open AccessA common outcome set for trials in dementia with Lewy bodies (DLB COS)
INTRODUCTION: Methodological heterogeneity in dementia with Lewy bodies (DLB) trials contributes to publication bias and makes evidence synthesis and meta‐analysis challenging. We aimed to develop a core outcome set for DLB (DLB COS) trials to improve consistency and comparability in DLB research. METHODS: We conducted a systematic review to identify outcomes and administered a two‐stage Delphi survey to a diverse panel of lay and professional stakeholders. We asked respondents which outcomes should be prioritized and included in DLB COS. RESULTS: Forty‐nine outcomes were presented to survey respondents. Consensus was reached regarding eight outcomes for the final DLB COS: delusions/paranoia; fluctuations in cognition, attention, and arousal; functioning; global cognition; hallucinations; quality of life; motor parkinsonism; and rapid eye movement sleep behavior disorder. DISCUSSION: If adopted, DLB COS can enhance the comparability of research findings and facilitate standardization and harmonization. Highlights: A systematic review revealed heterogeneity in dementia with Lewy bodies (DLB) study outcomes. Our study produced a DLB Core Outcome Set (DLB COS) comprising eight outcomes. DLB COS sets the minimum reporting standards for future trials. DLB‐specific rating scales incorporating these outcomes are needed. Addressing this gap is a strategic priority in DLB research.